Literature DB >> 6111723

Antihypertensive and adrenergic receptor blocking properties of the enantiomers of medroxalol.

H C Cheng, O K Reavis, J M Grisar, G P Claxton, D L Weiner, J K Woodward.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6111723     DOI： 10.1016/0024-3205(80)90534-2

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  4 in total

1.  Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol.

Authors:  H L Elliott; P A Meredith; D J Sumner; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1984-05       Impact factor: 4.335

2.  Stereochemistry, a basis for sophisticated nonsense in pharmacokinetics and clinical pharmacology.

Authors:  E J Ariëns
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

3.  Pharmacokinetics of (+)-rolipram and (-)-rolipram in healthy volunteers.

Authors:  W Krause; G Kühne; N Sauerbrey
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Further studies on (+/-)-YM-12617, a potent and selective alpha 1-adrenoceptor antagonist and its individual optical enantiomers.

Authors:  K Honda; C Nakagawa; M Terai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.